Breaking barriers for glioblastoma with a path to enhanced drug delivery
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Progress in treatment for glioblastoma is hindered by the blood-brain barrier (BBB). In genetic mouse models recapitulating brain invasion and abnormal angiogenesis of human glioblastoma, Cai and colleagues demonstrate that optical modulation of the BBB with nanoparticles boosts intratumoural chemotherapy concentration, prolonging survival. We discuss prospects for clinical translation of exemplary innovative techniques.
Description
Acknowledgements: Figures were created with BioRender.com. I.N. is funded by an National Institute of Health Research Clinical Lectureship, a Cancer Research UK Therapeutic Catalyst Award, University College London Biomedical Research Centre, the Academy of Medical Sciences and The Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001169), the UK Medical Research Council (FC001169) and the Wellcome Trust (FC001169). J.d.l.R. is a recipient of a grant from the Prostate Cancer Research (PCR).
Funder: Cancer Research UK (CRUK); doi: https://doi.org/10.13039/501100000289
Funder: Wellcome Trust (Wellcome); doi: https://doi.org/10.13039/100004440
